12/30: GOLD SHOCK COMING

Hey there, bargain hunter. Yesterday, Wendy’s board unanimously told Nelson Peltz to go flip his own burgers. An independent committee rejected the $7.35-per-share cash offer from Trian, Flynn Group, BlueFive Capital, and Sixth Street Partners. The committee said the bid “substantially undervalues” the company. Then, to make sure Peltz cannot quietly buy his way to control, the board adopted a one-year shareholder rights plan expiring November 3, 2027.

Scoreboard

• The proposal valued Wendy’s equity at approximately $1.4 billion, seeking to acquire all outstanding shares not already owned by the investor group.
• The group offered $7.35 per share in cash, a premium of about 20% at the time of the bid.
• WEN trades around $7.94 as of today.
• Trian and related parties own approximately 16.3% of Wendy’s. Flynn Group is a major Wendy’s franchise operator, but Wendy’s public filings around the bid do not specify how many Wendy’s restaurants Flynn operates.
• Wendy’s named Peltz chairman emeritus in September 2024 after he resigned from the board. Peter May and Bradley G. Peltz still sit on Wendy’s board.

What Actually Happened

Trian’s offer came about three months after Wendy’s withdrew its annual forecast, cut its dividend, and launched a turnaround plan under new CEO Bob Wright after reporting second-quarter revenue below Wall Street estimates and a decline in U.S. same-restaurant sales. Peltz saw a business in distress and moved. The board, freshly armed with a new strategy, said no.

The “Dave’s Way” plan focuses on menu value, digital engagement, and growth to address traffic declines and operational pressures. On the same morning the board rejected the bid, Wendy’s reported Q3 revenues of $547.0 million, global systemwide sales of approximately $3.3 billion, net income of $15.1 million, and adjusted EBITDA of $113.4 million, alongside $174 million in free cash flow year-to-date through the first nine months of the year.

The Real Numbers

Here is what makes the valuation question thorny. The beat-the-consensus story is real: Wendy’s posted adjusted EPS of $0.13 for Q3. But the “five consecutive quarters” beat streak, the $0.09 consensus number, and the specific percentage drops cited below are not supported by Wendy’s Q3 release or filing language, so treat the quarter as a mixed bag instead of a clean beat story. The underlying business is still soft, with U.S. same-restaurant sales down 5.7% in Q3.

Debt is still the hangover. As of September 27, 2026, Wendy’s reported approximately $2.7 billion of outstanding debt on its balance sheet. The earlier $4.07 billion figure does not match the company’s Q3 filing.

Also, the valuation math in the original draft does not hold together with the latest verified figures. At $7.94 and a market cap of about $1.52 billion, Wendy’s is trading closer to roughly 15.6x trailing earnings based on about $0.51 in EPS, not 11.6x on $0.66. The stock is above Peltz’s $7.35 bid, but that gap can also reflect takeover optionality and deal odds, not just agreement with the board.

Is It Cheap?

Peltz’s $7.35 implied an equity value of about $1.4 billion. Wendy’s trailing revenue is roughly $2.2 billion, putting that bid at a price-to-sales multiple around 0.6x. Restaurant peers like McDonald’s trade at multiples of that. But McDonald’s does not have a mid-single-digit U.S. same-store sales decline, and Wendy’s is trying to execute a turnaround while managing meaningful leverage.

Wendy’s is not the only quick-service chain betting that heavy discounting can reverse a traffic slide. Domino’s ran four separate half-price weeks in a single year to test whether deal-driven traffic converts into durable same-store sales recovery.

Now the chess game starts. The investor group will need to decide whether to sweeten the offer, stage a proxy fight, or get on board with CEO Bob Wright’s turnaround. Wendy’s reported approximately $413 million in cash and $174 million of free cash flow year-to-date, which management cited as evidence the company has the financial capacity to fund Dave’s Way. That is a real cushion, not a fiction.

Bull / Base / Bear

• Bull: Dave’s Way works. Same-store sales inflect positive by mid-2027. A second, higher bid from Trian or a third party values the chain closer to $10. The prior $5.94 low holds as the floor.
• Base: Sales stabilize but do not recover fast. Peltz eventually raises his offer modestly to roughly $8.50. Shareholders take the exit. No heroics needed.
• Bear: If sales remain stagnant, Peltz and Trian will gain more leverage and potentially more board seats. A prolonged proxy fight distracts management exactly when focus matters most. Debt load becomes a constraint on investment.

Action Plan

Do not buy the stock chasing takeover speculation at $7.94, which is already above the rejected bid. If you want exposure, the entry worth watching is a pullback toward $6.75 to $7.00. That is where the takeover floor provides real support and Dave’s Way optionality is not fully priced in. Trim or avoid above $8.50 until a confirmed bid or a quarter of positive U.S. same-store sales is on the table.

Cheap Investor Checklist

• U.S. same-restaurant sales trend: watch for sequential improvement beyond the 130-basis-point gain in Q3
• Trian’s next move: sweetened bid, proxy filing, or silence within 60 days
• Dave’s Way spending: watch whether corporate overhead and related costs stop outgrowing revenue as the rollout matures
• Free cash flow: $174 million year-to-date is solid; watch Q4 to confirm it holds above $200 million for the full year
• Debt service: about $2.7 billion in debt requires EBITDA stabilization; a further EBITDA decline below $100 million per quarter changes the risk calculus
• Poison pill expiry: November 3, 2027 is the clock. Any deal likely happens before then or not at all

Bottom Line

If Dave’s Way produces measurable traffic recovery by mid-2027, the board was right and Peltz’s $7.35 was a low-ball. If U.S. same-store sales are still falling six months from now, Peltz has a strong argument that he is the more credible operator in the room. The stock at $7.94 is a bet on Wright, not on a buyout. Know which one you are making before you act.